Twelve Points Wealth Management LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1877090 CONCORD, MA

Position in GILD

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$479,207

-$48,865 QoQ

Shares Held

3,793

+0.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.20%

of 13F equity value

Holder Rank

#1,391

of 2,266 holders

Holding Since

Dec 2021

11 quarters on record

Voting authority Sole 25% Shared 0% None 75%

Healthcare · as of Jun 30, 2026

Twelve Points Wealth Management LLC holds $8,917,030 across 7 Drug Manufacturers - General names. GILD ranks #6 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	11,534	$2,929,289
2	MRK	Merck & Co., Inc.	13,661	$1,755,438
3	ABBV	AbbVie Inc.	4,906	$1,234,545
4	AMGN	Amgen Inc	3,235	$1,171,458
5	LLY	ELI LILLY & Co	925	$1,109,472
6	GILD	Gilead Sciences, Inc. This page	3,793	$479,207
7	PFE	Pfizer Inc	9,868	$237,621

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$479,207	3,793	+0.1%	Shares	Sole	2026-08-07
2026-03-31	$528,072	3,789	-7.3%	Shares	Sole	2026-04-14
2025-12-31	$501,761	4,088	-24.8%	Shares	Sole	2026-01-23
2025-09-30	$603,729	5,439	-16.3%	Shares	Sole	2025-10-22
2025-06-30	$720,544	6,499	+1.5%	Shares	Sole	2025-07-16
2025-03-31	$717,232	6,401	-3.2%	Shares	Sole	2025-04-30
2024-12-31	$611,119	6,616	+11.4%	Shares	Sole	2025-01-23
2022-09-30	$366,376	5,939	+0.1%	Shares	Sole	2022-10-20
2022-06-30	$366,595	5,931	+0.7%	Shares	Sole	2022-07-18
2022-03-31	$350,101	5,889	-14.3%	Shares	Sole	2022-05-11
2021-12-31	$498,830	6,870	—	Shares	Sole	2022-03-18
No filing history on record for this holder in this stock.